Research

The DolPHIN 2 programme comprises clinical research, a qualitative study and a pharmacoeconomic study. Learn more about each strand of the project by clicking the boxes below.

Clinical Trial

The DolPHIN 2 Clinical Trial commenced recruitment in January 2018 and is designed to yield high-quality evidence on the efficacy and safety of dolutegravir.

Qualitative Research

The DolPHIN 2 qualitative study seeks to explore factors that influence late antenatal initiation and the adherence to and retention in cART programmes in pregnancy.

Health Economics

Health economic analysis led by the Infectious Diseases Institute will examine costs, and cost-effectiveness of dolutegravir.

Community Voices

Collaboration with the community is at the heart of DolPHIN 2. Click here to learn more about our community engagement, and to hear from some of our study participants.

DolPHIN2

Search

Research

Clinical Trial

Qualitative Research

Health Economics

Community Voices

Contact us

Follow us